Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455]
1 Department of Medical Oncology, University Hospital of Basel, Basel. Electronic address: [email protected].
2 Swiss Group for Clinical Cancer Research (SAKK), Bern.
3 Department of Radiation Oncology, University Hospital of Zurich, Zurich.
4 Department of Thoracic Surgery, University Hospital of Zurich, Zurich.
5 Clinics for Thoracic Surgery, Bethanien, Zurich.
6 Department of Medical Oncology, University Hospital of Basel, Basel.
7 Department of Medical Oncology, University Hospital of Bern (Inselspital), Bern.
8 Department of Oncology, University Hospital of Geneva, Geneva.
9 Department of Oncology, Cantonal Hospital of Graubünden, Chur.
10 Clinics of Medical Oncology, Cantonal Hospital of Fribourg (HFR), Fribourg.
11 Clinics for Thoracic Surgery, Hôpital du Valais, Sion, Switzerland.
12 Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA.
13 Department of Medical Oncology, University Hospital of Zurich, Zurich.
14 Department of Medical Oncology, University Hospital of Lausanne (CHUV), Lausanne.
15 Department of Medical Oncology, Cantonal Hospital of Winterthur, Winterthur.
16 Department of Medical Oncology, University Hospital of Bern (Inselspital), Bern; Department of Medical Oncology/Hematology, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland.